BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33740545)

  • 61. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
    Marisa L; de Reyniès A; Duval A; Selves J; Gaub MP; Vescovo L; Etienne-Grimaldi MC; Schiappa R; Guenot D; Ayadi M; Kirzin S; Chazal M; Fléjou JF; Benchimol D; Berger A; Lagarde A; Pencreach E; Piard F; Elias D; Parc Y; Olschwang S; Milano G; Laurent-Puig P; Boige V
    PLoS Med; 2013; 10(5):e1001453. PubMed ID: 23700391
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neuroendocrine carcinoma and mixed neuroendocrine‒non-neuroendocrine neoplasm of the stomach: a clinicopathological and exome sequencing study.
    Ishida S; Akita M; Fujikura K; Komatsu M; Sawada R; Matsumoto H; Saegusa J; Itoh T; Kakeji Y; Zen Y
    Hum Pathol; 2021 Apr; 110():1-10. PubMed ID: 33359239
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Up-regulation of macrophage wnt gene expression in adenoma-carcinoma progression of human colorectal cancer.
    Smith K; Bui TD; Poulsom R; Kaklamanis L; Williams G; Harris AL
    Br J Cancer; 1999 Oct; 81(3):496-502. PubMed ID: 10507776
    [TBL] [Abstract][Full Text] [Related]  

  • 64. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.
    Sinicrope FA; Foster NR; Thibodeau SN; Marsoni S; Monges G; Labianca R; Kim GP; Yothers G; Allegra C; Moore MJ; Gallinger S; Sargent DJ
    J Natl Cancer Inst; 2011 Jun; 103(11):863-75. PubMed ID: 21597022
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Are all RAS mutations the same? Coexisting KRAS and NRAS mutations in a caecal adenocarcinoma and contiguous tubulovillous adenoma.
    Vagaja NN; Parry J; McCallum D; Thomas MA; Bentel JM
    J Clin Pathol; 2015 Aug; 68(8):657-60. PubMed ID: 25926041
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Poorly differentiated medullary carcinoma of the colon with an unusual phenotypic profile mimicking high grade large cell lymphoma - a unique case report and review of the literature.
    Nguyen J; Coppola D; Shan Y; Zhang L
    Int J Clin Exp Pathol; 2014; 7(2):828-34. PubMed ID: 24551312
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The adenoma-adenocarcinoma sequence in the large bowel: variations on a theme.
    Hamilton SR
    J Cell Biochem Suppl; 1992; 16G():41-6. PubMed ID: 1335099
    [TBL] [Abstract][Full Text] [Related]  

  • 68. DNA ploidy and morphology of colon tumors in the adenoma-carcinoma sequence.
    Staarmann J; Kotb WF; Petersen I
    Folia Histochem Cytobiol; 2015; 53(1):11-8. PubMed ID: 25677247
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Colon adenoma and adenocarcinoma with clear cell components - two case reports.
    Oyama Y; Nishida H; Kusaba T; Kadowaki H; Arakane M; Okamoto K; Wada J; Urabe S; Daa T
    Diagn Pathol; 2019 May; 14(1):37. PubMed ID: 31077226
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lymph node yield after colectomy for cancer: is absence of mismatch repair a factor?
    Samdani T; Schultheis M; Stadler Z; Shia J; Fancher T; Misholy J; Weiser MR; Nash GM
    Dis Colon Rectum; 2015 Mar; 58(3):288-93. PubMed ID: 25664706
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Frequency of Mismatch Repair Protein Deficiency in a Puerto Rican Population with Colonic Adenoma and Adenocarcinoma.
    Reverón D; López C; Gutiérrez S; Sayegh ZE; Antonia T; Dutil J; Malafa M; Coppola D
    Cancer Genomics Proteomics; 2018; 15(4):265-271. PubMed ID: 29976631
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A Case Report of Metachronous Multiple Adenosquamous Carcinoma of the Colon Over-expressing PD-L1 and a Literature Review.
    Akahoshi S; Yamamura K; Komohara Y; Yoshii D; Oda E; Sato N; Yuki H; Yukimura K; Beppu T
    Anticancer Res; 2021 Nov; 41(11):5847-5854. PubMed ID: 34732461
    [TBL] [Abstract][Full Text] [Related]  

  • 73. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.
    Farchoukh L; Kuan SF; Dudley B; Brand R; Nikiforova M; Pai RK
    Am J Surg Pathol; 2016 Oct; 40(10):1390-9. PubMed ID: 27438990
    [TBL] [Abstract][Full Text] [Related]  

  • 74. New genetic variations discovered in KRAS wild-type cetuximab resistant chinese colorectal cancer patients.
    Jing C; Wang T; Ma R; Cao H; Wang Z; Liu S; Chen D; Zhang J; Wu Y; Zhang Y; Wu J; Feng J
    Mol Carcinog; 2020 May; 59(5):478-491. PubMed ID: 32141150
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials.
    Sinicrope FA; Shi Q; Allegra CJ; Smyrk TC; Thibodeau SN; Goldberg RM; Meyers JP; Pogue-Geile KL; Yothers G; Sargent DJ; Alberts SR
    JAMA Oncol; 2017 Apr; 3(4):472-480. PubMed ID: 28006055
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clear cell adenocarcinoma of the colon is a unique morphological variant of intestinal carcinoma: case report with molecular analysis.
    Barisella M; Lampis A; Perrone F; Carbone A
    World J Gastroenterol; 2008 Nov; 14(42):6575-7. PubMed ID: 19030216
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Colorectal Adenocarcinomas Harboring ALK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 12 Cases and Review of the Literature.
    Lasota J; Chłopek M; Wasąg B; Kowalik A; Christiansen J; Lamoureux J; Kuźniacka A; Felisiak-Gołąbek A; Liu Y; Reyes TAR; Saha R; Agaimy A; Behenska K; Biernat W; Cattaneo L; Centonze G; Daum O; Daumova M; Domagała P; Dziuba I; Geppert CE; Góźdź S; Nasierowska-Guttmejer A; Hałoń A; Hartmann A; Inaguma S; Iżycka-Świeszewska E; Kaczorowski M; Kołos M; Kopczyński J; Michal M; Milione M; Okoń K; Pęksa R; Pyzlak M; Ryś J; Waloszczyk P; Wejman J; Miettinen M
    Am J Surg Pathol; 2020 Sep; 44(9):1224-1234. PubMed ID: 32804454
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinicopathologic characteristics of FBXW7-mutated colorectal adenocarcinoma and association with aberrant beta-catenin localization.
    Escobar D; Bushara O; Sun L; Liao J; Yang GY
    Hum Pathol; 2022 Jan; 119():51-58. PubMed ID: 34717891
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neutrophils Restrict Tumor-Associated Microbiota to Reduce Growth and Invasion of Colon Tumors in Mice.
    Triner D; Devenport SN; Ramakrishnan SK; Ma X; Frieler RA; Greenson JK; Inohara N; Nunez G; Colacino JA; Mortensen RM; Shah YM
    Gastroenterology; 2019 Apr; 156(5):1467-1482. PubMed ID: 30550822
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma.
    Michelassi F; Ayala JJ; Balestracci T; Goldberg R; Chappell R; Block GE
    Ann Surg; 1991 Jul; 214(1):11-8. PubMed ID: 2064465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.